The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE In Correction Territory As Virus Fears Mount

Thu, 27th Feb 2020 17:12

(Alliance News) - The FTSE 100 suffered its biggest intraday fall since the Brexit referendum in 2016, joining a global stock market sell-off as the spread of coronavirus continued to widen.

Around 2,800 people have died in China and more than 80,000 have been infected. There have been more than 50 deaths and 3,600 cases in dozens of other countries, raising fears of a pandemic.

With 14 deaths and 528 infections, Italy is by far the European country worst affected by the COVID-19 outbreak. It has also been a point of contagion with many cases in other countries involving people who returned home after travelling in infection-hit areas of northern Italy.

In Japan, Prime Minister Shinzo Abe called for school closures to prevent the spread of the illness, while French President Emmanuel Macron warned the country is "facing a crisis, an epidemic that is coming".

The virus continues to spread across the globe, with Brazil reporting Latin America's first case, and Greece, Georgia, Norway and Pakistan following suit.

The FTSE 100 index closed down 246.07 points, or 3.5%, at 6,796.40. The large cap index, which closed up 0.4% at 7,042.47 on Wednesday, fell to an intraday low of 6,729.99 in afternoon trade - its lowest level in 13 months and down 10% from its peak in mid-January.

The FTSE 250 ended down 839.50 points, or 4.1%, at 19,783.45, and the AIM All-Share closed down 24.20 points, or 2.7%, at 886.96.

The Cboe UK 100 ended down 3.4% at 11,516.62, the Cboe UK 250 closed down 3.9% at 17,848.68, and the Cboe Small Companies ended down 2.1% at 11,810.50.

In Paris the CAC 40 ended down 3.3%, while the DAX 30 in Frankfurt ended 3.2% lower.

"The coronavirus contagion is a rapidly evolving situation and fears of its spreading are intensifying as multiple reports of cases emerging across the globe add to the sense of panic. Clearly it is serious, and unfortunately there have been a number of deaths reported. At this point, the lack of understanding of the virus and how far it could spread generates fear, and this fear of the unknown is impacting on stock markets across the world," Willis Owen's Adrian Lowcock said.

"Up until this week markets were fairly relaxed about it as they hoped the impact was limited to China and thus the feed through to global growth would be short term and limited. That's changed now there have been significant breakouts in Italy particularly, and today a concerning case in the US. This has undoubtedly raised the possibility that it will become a global issue, and if this comes to pass this will have a much bigger impact on global growth and hit company profits," Lowcock added.

On the London Stock Exchange, Hikma Pharmaceuticals ended the best blue chip performer, up 4.3% after the drugmaker said it delivered a positive financial performance in 2019.

Hikma said group revenue in 2019 rose 7% to USD2.2 billion, compared to USD2.07 billion in 2018, reflecting good growth in each of the three business. Pretax profit grew to USD493 million from USD293 million in 2018, also reflecting strong performance of its three business segments.

By division, Injectables revenue grew 8% to USD894 million, "driven by strong demand" for the company's portfolio.

The company declared an annual dividend of 44 cents per share, an increase from 38 cents per share in 2018. The final dividend 30 cents, up from 26 cents. Looking ahead, the company said it expects its three business segments to grow in 2020. Hikma said it does not currently anticipate any material impact from coronavirus, since it does not have extensive operations in China.

Rentokil Initial closed up 0.5% after the pest control company upped its dividend by 15% following a "strong" annual performance in which it beat revenue growth targets. Rentokil declared a final dividend of 3.64 pence per share, taking the total to 5.15p, just over 15% higher than the payout in 2018.

The company swung to a pretax profit of GBP338.5 million, after a loss of GBP114.1 million in 2018. Rentokil's figure last year had been hit by a pension settlement worth nearly GBP350 million. Adjusted pretax profit was 11% higher at actual exchange rates, an 9.8% at constant currency, at GBP340.9 million. Rentokil achieved 9.8% revenue growth at actual exchange rates to GBP2.71 billion, with constant currency revenue growth 8.5%. Organic revenue growth was 4.5%, beating Rentokil's medium-term target of 3% to 4% annual organic growth.

Looking ahead, Rentokil said it has made a "good" start to 2020, and it has maintained medium-term growth targets.

At the other end of the large cap index, WPP ended the worst performer, down 16% after the advertising agency posted a double-digit profit slump.

From continuing operations, revenue for 2019 was up 1.4% to GBP13.23 billion from GBP13.05 billion, but pretax profit slumped 22% to GBP982 million from GBP1.26 billion.

The profit hit was largely due to it booking a GBP68.4 million hit from the revaluation of financial instruments, compared to a GBP169.4 million gain in 2018. Billings meanwhile, slipped 0.3% to GBP53.06 billion GBP53.22 billion. Like-for-like billings were down 1.0% in 2019.

For 2020, WPP expects revenue less pass-through costs to be flat year-on-year, although WPP said this guidance was made prior to any impact from the coronavirus outbreak.

"After a year of consolidation and modest progress, 2020 was supposed to be the year when CEO Mark Read really started to deliver, joined by newly appointed finance chief John Rogers. He is off to a very ropey start after reporting that underlying revenue slumped rather alarmingly in the fourth quarter of last year. The best investors can hope for now is zero growth and maintained margins in 2020. The targets for 2021 have been maintained but the market's patience appears to have snapped," said AJ Bell's Russ Mould.

In addition, travel stocks continued their freefall with TUI ending down 8.2%, easyJet down 4.2% and International Consolidated Airlines down 7.9%. The FTSE 350 travel & leisure sector closed down 4.8%.

Persimmon closed down 6.3% after the housebuilder's annual profit missed market expectations, with revenue and new home sales declining as the group prioritised the quality of sales over quantity.

In addition, Persimmon announced Chief Executive David Jenkinson will step down in due course, staying "for as long as the business requires".

For 2019, Persimmon reported pretax profit of GBP1.04 billion, down 4.6% from the year before, on revenue that declined by 2.4% to GBP3.65 billion. During the year, Persimmon delivered 15,885 new homes to customers, down 4% from 16,449 the prior year, but at an average selling price of GBP215,709, up marginally year-on-year.

The revenue decline was due to a lower volumes of homes sold, as Persimmon delayed sales releases in higher demand locations to later stages of construction in order to improve the quality of the group's homes.

The pound was quoted at USD1.2867 at the London equities close, down from USD1.2920 at the close Wednesday.

Analysts at FXPro told Alliance News: "The jump in new coronavirus cases outside of China sends key stock indices one after another to the correction territory when the drop from the peak exceeds 10%. Under these conditions, the thirst for the so-called safe havens increases sharply. In the currency markets of Britain and the United States, there is a rapid reassessment of prospects towards new rate cuts soon.

"Fear of the spread of coronavirus lead FTSE 100 to collapse by more than 3.3% on Thursday, and increased speculation around an imminent reduction in UK rates weakens the pound against the euro and to a lesser extent against the dollar."

Meanwhile, sterling's fall was compounded by fears UK Prime Minister Boris Johnson could walk away from trade talks with the EU in June unless there is the "broad outline" of a deal.

The UK's guidelines for the negotiations, which cover trade and other aspects of the future relationship with Brussels, sets the deadline for progress against a backdrop of deep divisions between the two sides over issues including fish, state subsidies and standards.

The UK government set out its plans for the talks ahead of the first round of negotiations on Monday, making clear that it "will not negotiate any arrangements in which the UK does not have control of its own laws and political life".

The euro stood at USD1.0984 at the European equities close, up from USD1.0866 late Wednesday. Against the yen, the dollar was trading at JPY110.58, flat from JPY110.52 late Wednesday.

Stocks in New York were sharply lower at the London equities close amid fears the coronavirus will lead to a recession in the world's largest economy.

Moreover, the losses came after US public health officials confirmed a coronavirus case in Solano County, California, the first affliction of unknown origin.

The DJIA was down 2.4%, the S&P 500 index down 2.5% and the Nasdaq Composite down 2.8%.

Yields on US Treasuries, which fall when prices rise, dropped below 1.26% for 10-year debt and 1.75% for the 30-year Treasury bond, as the as the coronavirus spread outside China - despite infections inside China starting to slow.

"Based solely on the yield curve, the odds of a recession have rebounded to more than 30%. But the strength of US building permits, albeit in part due to unseasonably warm weather, suggests the recession odds have fallen below 10%. The manufacturing data had also been improving, at least up to January, with the bounce-back in the ISM new orders index pointing to a lower recession risk," Capital Economics analysts said.

On the economic front, the US economy expanded at an unrevised annual rate of 2.1% in the fourth quarter, data from the Bureau of Economic Analysis showed.

The reading also matched the third quarter growth rate of 2.1%.

In addition, the personal consumption expenditures price index increased 1.3% in the fourth quarter, compared with an increase of 1.5% in the third. Excluding food and energy prices, personal consumption expenditure were up 1.2% versus 2.1% in the three months to September.

Brent oil was quoted at USD51.32 a barrel at the London equities close from USD54.45 at the close Wednesday. The North Sea benchmark - down for the fifth successive session - fell to an intraday low of USD50.96 in afternoon trade, its lowest level since December 2018.

Gold was quoted at USD1,655.10 an ounce at the London equities close, higher against USD1,637.00 late Wednesday, as demand for the safe haven asset increased amid virus fears.

The economic events calendar on Friday has Germany unemployment and inflation data at 0855 GMT and 1300 GMT respectively In the afternoon, there is US personal consumption expenditure figures at 1330 GMT - the core reading is the Fed's preferred gauge of inflation.

The UK corporate calendar on Friday has annual results from stock exchange operator London Stock Exchange Group, airline operator International Consolidated Airlines Group, Irish building materials firm CRH, property portal Rightmove and from jet engine maker Rolls-Royce Holdings.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
22 Feb 2024 09:42

TOP NEWS: Hikma boosts dividend after year of "significant progress"

(Alliance News) - Shares in Hikma Pharmaceuticals PLC jumped on Thursday after it lifted the dividend by 29% amid better-than-expected annual profit.

Read more
22 Feb 2024 07:51

Hikma lifts dividend after double-digit growth in 2023

(Sharecast News) - Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in 2023.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
2 Feb 2024 07:23

Hikma agrees to settle US opioid claims

(Sharecast News) - Hikma Pharmaceuticals announced an agreement in principle to address the majority of opioid-related claims filed against it by various US states, local communities and tribal nations on Friday.

Read more
1 Feb 2024 20:00

EARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2024 09:29

LONDON BROKER RATINGS: Berenberg cuts target prices for miners

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Wednesday:

Read more
20 Dec 2023 09:25

LONDON BROKER RATINGS: UBS cuts DS Smith; Kepler likes Genus

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
19 Dec 2023 09:11

LONDON BROKER RATINGS: Peel Hunt raises Flutter to 'buy' from 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 13:08

Jefferies downgrades Hikma to 'hold'

(Sharecast News) - Jefferies downgraded Hikma Pharmaceuticals on Tuesday to 'hold' from 'buy' and cut the price target to 1,940p from 2,125p.

Read more
7 Nov 2023 09:28

LONDON BROKER RATINGS: Watches of Switzerland impresses HSBC; Asos cut

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 07:43

LONDON BRIEFING: AB Foods hails Primark; Beazley premiums rise

(Alliance News) - London's FTSE 100 is called to open in the red on Tuesday, following Asian equities lower, as the good feeling in equity markets after the softer US jobs data on Friday gives way to some caution.

Read more
6 Nov 2023 12:01

Berenberg stays at 'hold' on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg reiterated their 'hold' rating and 2,100.0p target price on Hikma Pharmaceuticals on Monday, saying a "lighter" second half was playing out in its injectables unit.

Read more
3 Nov 2023 09:31

LONDON BROKER RATINGS: JPMorgan lifts Smith & Nephew

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
2 Nov 2023 15:12

London close: Stocks rise as BoE keeps rates steady

(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.